DULOXETINE HCL
MAJOR DEPRESSIVE DISORDER·+5
ZYDUS PHARMACEU
Indication
Fibromyalgia
Fibromyalgia is a chronic pain disorder characterized by widespread musculoskeletal pain, generalized tenderness, persistent fatigue, unrefreshing sleep, and cognitive disturbances. Read more about Fibromyalgia
99 drugs 62 manufacturers
Drugs that treat it
Common Fibromyalgia therapies.
SAVELLA (milnacipran HCl)
FIBROMYALGIA
ACTAVIS U.S. BR
SAVELLA (milnacipran HCl)
FIBROMYALGIA
ACTAVIS U.S. BR
DULOXETINE HCL
ANTIDEPRESSANTS·MAJOR DEPRESSIVE DISORDER·+5
CAMBER PHARMACE
DULOXETINE HCL
MAJOR DEPRESSIVE DISORDER·+5
MYLAN INSTITUTI
SAVELLA (milnacipran HCl)
ANTIDEPRESSANTS·FIBROMYALGIA
Allergan
SAVELLA (milnacipran HCl)
ANTIDEPRESSANTS·FIBROMYALGIA
Allergan
DULOXETINE HCL
ANTIDEPRESSANTS·MAJOR DEPRESSIVE DISORDER·+5
AJANTA PHARMA L
DULOXETINE HCL
ANTIDEPRESSANTS·MAJOR DEPRESSIVE DISORDER·+5
Actavis Pharma
Filter & compare in the drug finder →Opens the drug finder with Fibromyalgia preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonFibromyalgia is a chronic pain disorder characterized by widespread musculoskeletal pain, generalized tenderness, persistent fatigue, unrefreshing sleep, and cognitive disturbances.
Primarily affecting adults, particularly women, the condition involves the central nervous system and is classified pathophysiologically as a nociplastic pain state.
Its defining hallmark is central sensitization, wherein altered sensory and central pain processing mechanisms lead to amplified pain signaling, hyperalgesia, and allodynia in the absence of ongoing structural tissue injury or systemic inflammation.
- nih.gov
Fibromyalgia is a chronic pain disorder characterized by widespread musculoskeletal pain, generalized tenderness, persistent fatigue, unrefreshing sleep, and cognitive disturbances
- nih.gov
Fibromyalgia is a chronic pain disorder characterized by widespread musculoskeletal pain, generalized tenderness, persistent fatigue, unrefreshing sleep, and cognitive disturbances Its defining hallmark is central sensitization, wherein altered sensory and central pain processing mechanisms lead to amplified pain signaling, hyperalgesia, and allodynia in the absence of ongoing structural tissue injury or systemic inflammation
- medlineplus.gov
Primarily affecting adults, particularly women, the condition involves the central nervous system and is classified pathophysiologically as a nociplastic pain state
- nih.gov
Primarily affecting adults, particularly women, the condition involves the central nervous system and is classified pathophysiologically as a nociplastic pain state
- nih.gov
Its defining hallmark is central sensitization, wherein altered sensory and central pain processing mechanisms lead to amplified pain signaling, hyperalgesia, and allodynia in the absence of ongoing structural tissue injury or systemic inflammation
Personalize your experience
Follow Fibromyalgia and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.